8-K: Safe & Green Holdings Restructures Financing to Address Nasdaq Concerns, Issues New Preferred Stock

Safe & Green Holdings Corp. has entered into an Exchange Agreement to convert previously issued warrants into Series B Preferred Stock, aiming to resolve Nasdaq's concerns regarding its prior financing structure and commit to non-dilutive funding strategies.

Summary

• Safe & Green Holdings Corp. (SGBX) entered into an Exchange Agreement on July 17, 2025, with investors to exchange Series A and Series B Warrants from an April 14, 2025 private placement.
• The exchange is for an aggregate of 60,000 shares of newly designated Series B Convertible Preferred Stock, each with a stated value of $1,000 per share.
• The primary motivation for this transaction is to address concerns raised by Nasdaq regarding the structure of the April 2025 private placement, particularly concerning the Series B Warrants.
• The Series B Preferred Stock has a conversion price of the lesser of $0.392 and the greater of 90% of the lowest daily VWAP over 10 trading days or a floor price of $0.20.
• Holders of Series B Preferred Stock are entitled to dividends equal to and in the same form as dividends paid on Common Stock, on an as-if-converted basis.
• Voting rights for the Series B Preferred Stock are limited to 19.99% until shareholder approval is obtained, based on the Nasdaq Minimum Price.
• The company has committed to ceasing all forms of dilutive financing and intends to pursue alternative, non-dilutive funding strategies for long-term growth and stability.
• A registration statement covering the resale of the new securities is required to be filed by July 28, 2025.
• Shareholder approval for the Series B Preferred Stock is sought at the 2025 Special Shareholders Meeting on August 25, 2025, with subsequent meetings every four months if not obtained.
• The company will apply 50% of all proceeds from future financings, including equity lines of credit, towards the pro-rata redemption of the Preferred Stock at its stated value.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the need for the exchange stems from prior issues and Nasdaq concerns, the company's proactive measures to address these concerns, commitment to non-dilutive financing, and inclusion of strong investor protections in the new preferred stock terms are positive steps towards stability and improved corporate governance. However, the underlying issues and potential for future delays or penalties temper the overall positive outlook.

Positives

• Proactive steps taken to address Nasdaq's concerns regarding the structure of the April 2025 private placement, which could help maintain Nasdaq listing compliance.
• Commitment to cease all forms of dilutive financing and pursue alternative, non-dilutive funding strategies, which is positive for existing shareholder equity and market perception.
• Management's stated commitment to transparent and responsible capital management.
• The new Series B Preferred Stock includes protective provisions for holders, such as anti-dilution adjustments, participation rights in future financings, and liquidated damages for certain failures by the company.

Negatives

• The need for this exchange indicates prior financing activities (April 2025 private placement) had structural issues that raised Nasdaq concerns.
• The company's past dilutive financing activities have negatively impacted shareholder equity and market perception, as acknowledged by management.
• Potential for future dilution if shareholder approval for the Series B Preferred Stock (especially for conversions exceeding 19.99% of outstanding common stock) is not obtained.
• The company may incur liquidated damages if it fails to meet registration statement deadlines or deliver conversion shares in a timely manner.

Risks

• Failure to obtain shareholder approval for the Series B Preferred Stock, which could limit conversion rights and potentially lead to further issues with Nasdaq.
• Risk of delisting from Nasdaq if compliance issues persist or are not fully resolved.
• Potential for significant liquidated damages if the company fails to file or maintain the effectiveness of the registration statement, or fails to deliver conversion shares promptly.
• The company's ability to secure alternative, non-dilutive funding strategies is not guaranteed and could impact long-term growth and stability.
• The company's common stock could be subject to a 'chill' or electronic transfer issues through the Depository Trust Company, impacting liquidity.
• Monetary judgments exceeding $50,000 against the company or its subsidiaries, if unvacated or unstayed for 45 days, could trigger redemption obligations.

Future Outlook

The company is committed to ceasing all forms of dilutive financing and intends to pursue alternative, non-dilutive funding strategies to support long-term growth and stability. It plans to obtain shareholder approval for the Series B Preferred Stock at the upcoming 2025 Special Shareholders Meeting on August 25, 2025, and will continue to seek such approval every four months if not initially obtained. The company also plans to file a registration statement for the resale of the new securities by July 28, 2025.

Management Comments

• "The Company hereby affirms its commitment to maintaining shareholder value and compliance with Nasdaq listing standards."
• "Management recognizes the impact that past dilutive financing activities may have had on shareholder equity and market perception, and has taken concrete steps to pursue alternative, non-dilutive funding strategies to support the Company's long-term growth and stability."
• "The Company is fully committed to transparent and responsible capital management in alignment with the expectations of the Nasdaq Capital Market."

Industry Context

This filing reflects a broader trend of increased scrutiny by regulatory bodies like Nasdaq on financing structures that could be perceived as overly dilutive or detrimental to shareholder value. Companies, especially those with lower market capitalizations, often face challenges in securing non-dilutive funding, leading to complex financing arrangements. The company's proactive steps to address Nasdaq's concerns and commit to non-dilutive strategies align with a growing investor preference for sustainable capital management practices.

Comparison to Industry Standards

• The company's commitment to cease dilutive financing and pursue non-dilutive strategies aligns with best practices for maintaining shareholder value, contrasting with companies that frequently resort to highly dilutive equity raises.
• The inclusion of robust anti-dilution provisions, participation rights in future financings, and liquidated damages for non-compliance in the Series B Preferred Stock terms provides a level of investor protection that is often sought in private placement agreements, comparable to terms seen in venture capital or institutional debt agreements for growth-stage companies.
• The requirement for shareholder approval for voting rights exceeding 19.99% and the overall exchange to address Nasdaq concerns highlight the importance of compliance with exchange listing rules, a standard expectation for all publicly traded companies, similar to how other companies like XYZ Corp. or ABC Inc. have adjusted their capital structures to meet regulatory requirements after receiving deficiency notices.

Corporate Governance

Stakeholder Impact

• **Shareholders:** The exchange aims to address Nasdaq concerns, potentially stabilizing the stock and preventing further regulatory issues. The commitment to non-dilutive financing is positive for existing equity holders. However, the need for the exchange highlights past dilutive practices. Shareholder approval is required for full voting rights of the new preferred stock, giving them a say in future capital structure.
• **Investors (Holders of Series B Preferred Stock):** These investors receive new preferred stock with defined rights, including conversion options, dividend entitlements, and liquidation preferences. They also benefit from anti-dilution provisions, participation rights in future financings, and liquidated damages clauses for company non-compliance, offering significant protections.
• **Nasdaq:** The transaction directly addresses Nasdaq's concerns regarding the structure of the April 2025 financing, indicating the company's efforts to maintain compliance with listing standards.

Next Steps

• File a Current Report on Form 8-K by July 23, 2025, including the Transaction Documents.
• File a registration statement covering the resale of the securities by July 28, 2025.
• Seek shareholder approval for the Series B Preferred Stock at the 2025 Special Shareholders Meeting on August 25, 2025.
• If shareholder approval is not obtained, call a meeting every four months thereafter until approval is secured.
• Apply 50% of proceeds from future financings towards the redemption of the Preferred Stock.
• Maintain compliance with Nasdaq listing standards and current public information requirements under Rule 144.

Key Dates

Recommendation

Keywords

SEC Filing, Exchange Agreement, Preferred Stock, Warrants, Nasdaq Compliance, Dilutive Financing, Non-Dilutive Funding, Corporate Governance, Shareholder Approval, Registration Rights, SGBX, Capital Management